sulfinpyrazone has been researched along with thromboxane b2 in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (94.44) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, M; Cerskus, AL; McDonald, JW; Zamecnik, J | 2 |
| Bauman, JE; Domoto, DT; Joist, JH | 1 |
| Ambler, J; Butler, KD; Butler, PA; Shand, RA; Wallis, RB | 1 |
| FitzGerald, GA; Pedersen, AK | 1 |
| Toivanen, J; Viinikka, L; Ylikorkala, O | 1 |
| Catella, F; Ciabattoni, G; Davì, G; Filabozzi, P; Forni, L; Patrignani, P; Patrono, C; Pugliese, F | 1 |
| Wallis, RB | 1 |
| Cerletti, C; De Gaetano, G; Del Maschio, A; Livio, M | 1 |
| Lewis, GP; Smith, JR | 1 |
| Dahl, ML; Uotila, P | 1 |
| O'Flaherty, JT; Stimler, NP | 1 |
| Antoniazzi, V; Binaghi, G; Boscarini, M; Boschetti, C; Cortellaro, M; Limido, A; Moreo, G; Polli, EE; Repetto, S; Verna, E | 1 |
| Beamish, RE; Dhalla, NS; Karmazyn, M; Moffat, MP | 1 |
| Lorenz, R; Siess, W; Weber, PC | 1 |
| Ali, M; Cooper, JD; Duffin, J; Klement, P; Masterson, J; McDonald, JW; Thiesson, JJ; Townsend, ER | 1 |
| Ali, M; Cooper, JD; Klement, P; Masterson, J; McDonald, JW; Menkes, E | 1 |
| Ali, M; Cerskus, AL; McDonald, JW | 1 |
2 review(s) available for sulfinpyrazone and thromboxane b2
| Article | Year |
|---|---|
Clinical pharmacology of platelet cyclooxygenase inhibition.
Topics: Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Epoprostenol; Fibrinolytic Agents; Humans; Sulfinpyrazone; Sulindac; Thromboxane B2; Time Factors | 1985 |
Mechanisms of action of sulphinpyrazone.
Topics: Animals; Blood Platelets; Cattle; Cyclooxygenase Inhibitors; Humans; In Vitro Techniques; Male; Seminal Vesicles; Sulfinpyrazone; Thromboxane B2 | 1983 |
1 trial(s) available for sulfinpyrazone and thromboxane b2
| Article | Year |
|---|---|
Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis.
Topics: Aspirin; Blood Coagulation Tests; Blood Platelets; Catheters, Indwelling; Drug Evaluation; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Recurrence; Renal Dialysis; Sulfinpyrazone; Thrombosis; Thromboxane B2 | 1991 |
15 other study(ies) available for sulfinpyrazone and thromboxane b2
| Article | Year |
|---|---|
Effects of indomethacin and sulfinpyrazone on in vivo formation of thromboxane B2 and prostaglandin D2 during arachidonate infusion in rabbits.
Topics: Animals; Arachidonic Acids; Blood Platelets; Female; Indomethacin; Infusions, Parenteral; Platelet Aggregation; Prostaglandins; Prostaglandins D; Rabbits; Respiratory Insufficiency; Sulfinpyrazone; Thromboxane B2; Thromboxanes | 1978 |
Synthesis of prostaglandin D2 and thromboxane B2 by human platelets.
Topics: Blood Platelets; Borohydrides; Chromatography, Gas; Chromatography, Thin Layer; Collagen; Humans; Mass Spectrometry; Phenylbutazone; Platelet Aggregation; Prostaglandins; Prostaglandins D; Sulfinpyrazone; Thromboxane B2; Thromboxanes | 1977 |
Prolongation of platelet survival in hypercholesterolaemic rabbits by CGS 12970 (3-methyl-2-(3-pyridyl)-1 indoleoctanoic acid) and dazoxiben.
Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Cholesterol, Dietary; Cyclooxygenase Inhibitors; Hypercholesterolemia; Imidazoles; Pyridines; Rabbits; Sulfinpyrazone; Thromboxane B2; Thromboxane-A Synthase | 1987 |
Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosing.
Topics: Adult; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Cyclooxygenase Inhibitors; Epoprostenol; Humans; Platelet Activating Factor; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Sulfinpyrazone; Thromboxane B2 | 1985 |
Differential inhibition of platelet thromboxane and lung prostacyclin production by sulphinpyrazone, acetylsalicylic acid and indomethacin by human tissues in vitro.
Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Epoprostenol; Humans; In Vitro Techniques; Indomethacin; Lung; Sulfinpyrazone; Thromboxane A2; Thromboxane B2 | 1985 |
Inhibition of human platelet cyclo-oxygenase activity by sulfinpyrazone and three of its metabolites.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Cyclooxygenase Inhibitors; Humans; In Vitro Techniques; Kinetics; Malondialdehyde; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Sulfinpyrazone; Thromboxane B2 | 1984 |
Prostaglandin endoperoxides and thromboxane A2 in thrombus formation in the hamster cheek pouch in vivo.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Cheek; Cricetinae; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Male; Mesocricetus; Microscopy, Electron; Platelet Aggregation; Sulfinpyrazone; Thrombosis; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1984 |
Thromboxane formation during blood clotting is decreased by verapamil.
Topics: Blood Coagulation; Blood Platelets; Humans; Indomethacin; Methacrylates; Sulfinpyrazone; Thromboxane B2; Thromboxanes; Verapamil | 1984 |
Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Aspirin; Blood Platelets; Catechols; Chromones; Dose-Response Relationship, Drug; Guinea Pigs; Indomethacin; Lung; Masoprocol; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; Rats; Sulfinpyrazone; Thromboxane B2 | 1983 |
Transcoronary platelet thromboxane A2 formation without platelet trapping in patients with coronary stenosis-effect of sulphinpyrazone treatment.
Topics: Adult; Aged; Angina Pectoris; Blood Platelets; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Count; Sulfinpyrazone; Thromboxane A2; Thromboxane B2; Thromboxanes | 1983 |
Comparative effects of acetylsalicylic acid (ASA) and sulfinpyrazone on isoproterenol-induced heart damage.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Urea Nitrogen; Creatine Kinase; Isoproterenol; Male; Myocardial Infarction; Prostaglandins F; Rats; Sulfinpyrazone; Thromboxane B2 | 1981 |
Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acids; Aspirin; Blood Platelets; Collagen; Dipyridamole; Dose-Response Relationship, Drug; Female; Humans; Male; Platelet Aggregation; Sulfinpyrazone; Thromboxane B2; Thromboxanes | 1981 |
Preservation of platelets during extracorporeal circulation in sheep. A comparison between aspirin and sulfinpyrazone.
Topics: Animals; Aspirin; Blood Platelets; Blood Preservation; Blood Pressure; Extracorporeal Circulation; Leukocyte Count; Oxygenators; Platelet Count; Pulmonary Artery; Sheep; Sulfinpyrazone; Thromboxane B2 | 1981 |
Prostaglandin production associated with the pulmonary vascular response to complement activation.
Topics: Animals; Blood Pressure; Cardiac Output; Complement Activation; Female; Indomethacin; Leukocyte Count; Male; Oxygen; Prostaglandins F; Pulmonary Artery; Pulmonary Circulation; Sheep; Sulfinpyrazone; Thromboxane B2; Vascular Resistance | 1980 |
Thromboxane B2 and 6-keto-prostaglandin F1 alpha synthesis during infusion of collagen and arachidonic acid in rabbits: inhibition by aspirin and sulfinpyrazone.
Topics: Animals; Arachidonic Acids; Aspirin; Blood Pressure; Collagen; Dose-Response Relationship, Drug; Female; Platelet Aggregation; Platelet Count; Prostaglandins F; Rabbits; Sulfinpyrazone; Thromboxane B2; Thromboxanes | 1980 |